Gene Therapy
New Gene Therapy study findings recently were reported by researchers at University of Rome
Published in Gene Therapy Weekly, September 20th, 2007
According to recent research from Rome, Italy, "Genetic heterogeneity in Nijmegen breakage syndrome (NBS) is highlighted by patients showing clinical and cellular features of NBS but with no mutations in NBS1 and normal levels of nibrin. NBS is an autosomal recessive disorder, whose clinical cellular signs include growth and developmental defects, dysmorphic facies, immunodeficiency, cancer predisposition, chromosomal instability and radiosensitivity."
"NBS is caused by mutations in the NBS1 gene, whose product is part of the MRE11/RAD50/ NBS1 complex involved in the DNA double-strand break (DSB) response pathway. Since the identification of the NBS1 gene, patients with...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-09-20)
More Articles from Gene Therapy Weekly
- Gene Therapy
Study details regulation of vital tumor suppressor gene p53 - Gene Therapy
CODA Genomics Announces Issuance of Optimized Synthetic Gene Production Patent - Gene Therapy
CytoGenix Announces Hiring of New Chief Financial Officer - Molecular Targets
The Molecular Profiling Institute Launches Mammostrat - a Novel, Molecular-Targeted, Prognostic Test for Breast Cancer Patients - Bioengineering
New bioengineering study findings reported from Martin-Luther University, Institute of Biochemistry and Biotechnology - Bioengineering
Research reports on bioengineering from Boston University, Center for Advanced Biotechnology provide new insights - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
